scholarly journals Contribution of Flow Cytometry to Acute Leukemia Classification in Tunisia

2000 ◽  
Vol 16 (3-4) ◽  
pp. 131-133 ◽  
Author(s):  
S. Feki ◽  
H. El Omri ◽  
M. A. Laatiri ◽  
S. Ennabli ◽  
K. Boukef ◽  
...  

The precision of immunological characterization of leukemias was improved by a certain number of technical innovations, particularly hybridoma production and standardization, resulting in monoclonal antibodies and definition of recognised cellular antigens (designated by CD: Cluster of Differentiation).The aim of this work was to determine the immunophenotyping profile of patients with leukemia, by means of a flow cytometric method: 66 blood samples coming from leukemic persons in the Sahel region were studied by flow cytometry, using about thirty monoclonal antibodies all marked with a fluorochrome, in one or two colour systems to assess their distribution according to type (lymphoid B or T / myeloid) and age, and to search for possible co-expressions of markers of different lineages.The marked preponderance of childhood B-ALL in our series is, at least partly, attributable to the age distribution of the Tunisian population. In agreement with studies from other countries, the majority of AML cases occurred among adults. A high proportion of AML cases in our series co-expressed markers of other lineages. Overall, accurate classification of acute leukemias was possible from a simple peripheral blood sample in 62 of 66 cases (93.9%).

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 5194-5194
Author(s):  
Aldair Sousa Paiva ◽  
Hugo Diogenes De Oliveira Paiva ◽  
Geraldo Barroso Cavalcanti ◽  
Frank Bahia ◽  
Rodrigo Villar Freitas ◽  
...  

Abstract Background: The detection of Intracellular (IC) antigens by flow cytometry (FC) such as myeloperoxidase (MPO), cCD13, cCD79a, cCD22, cCD3 and Terminal deoxynucleotidyl Transferase (TdT) has become the useful tool in the differential diagnosis between acute myeloid leukemias (AML) and acute lymphoid leukemias (ALL). Through detection of myeloid antigens (MPO and cCD13), B cells precursors (cCD79a and cCD22) and precocity T-cells (cCD3) it has been possible to confirm the diagnosis of these acute leukemias. The detection of intracellular cell markers by FC usually requires previous permeabilization of fresh cell suspensions. TdT, also known as DNA nucleotidylexotransferase (DNTT) or terminal transferase, is a specialized DNA polymerase expressed in immature, pre-B, pre-T lymphoid cells, and acute lymphoblastic leukemia/lymphoma cells. TdT adds N-nucleotides to the V, D, and J exons of the TCR and BCR genes during antibody gene recombination, enabling the phenomenon of junctional diversity. In humans, terminal transferase is encoded by the DNTT gene. This antigen is expressed mostly in the nucleus cells from primary lymphoid organs, like the thymus and bone marrow. The TdT detection has also been shown to be useful in confirming the acute forms of B and T-lineage lymphoproliferative diseases by FC. The aim of this study was to demonstrate the importance of this cell markers' detection by FC in the differential diagnostic of acute leukemias. Methods: Bone marrow and/or peripheral blood leukemic cells from 50 cases of acute leukemia: 16 ALL and 36 AML. The cells were fixed and permeabilized in briefly exposed to Becton & Dickinson Lyse Solution at concentration of 10%, and subsequently labeled with monoclonal antibodies anti-MPO, TdT, CD3, CD13, CD22 and CD79a. Results: The MPO expression was observed in 35/36(97,22%) and cCD13 in all cases of AML and in none ALL patients. Three cases of MPO-positive ALL (FAB-L2) could be reclassified as M0-AML. These cases were CD34+;HLADR+;CD33-;CD13-;CD7+ and cCD13+. The intensity of TdT expression was observed in 15/16 (93.8%) of ALL and 5/36 (13.9%) of AML. The cCD22 and cCD79a were positive in 15/16 (93.8%) and all of pre-B ALL respectively and cCD3 was expressed in one case of Pre-T ALL that initial phenotype was CD34+/HLADR+/TdT+/CD7+ and sCD3-). Conclusions: These results indicate that monoclonal antibodies anti-MPO, cCD13, cCD79a, cCD22, cCD3 and TdT were excellent cell markers for the diagnosis and classification of acute leukemias and can be reliably detected by FC. This rapid and specific technique should be a valuable addition to routine immunophenotyping of acute leukemia. Disclosures No relevant conflicts of interest to declare.


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 4726-4726
Author(s):  
Guat Bee Tan ◽  
Christina Sum ◽  
Ponnudurai Kuperan

Abstract Abstract 4726 Automated blood cell counters provide a leucocyte count and five-part (some 6-part) leucocyte differential, however haematology instrument differentials provide only limited information on cell morphology using abnormal cell flags and are often unable to reliably classify abnormal and immature cells. There are also limitations with the standard microscopic differential, identification of cells is subjective and there is significant inter and intra observer variation (Koepke et al. 1985). It is also subject to significant statistical variance (Rumke 1985). There have recently been reports of using monoclonal antibody cocktails for an extended leucocyte differential by flow cytometry. The International Council for Standardization in Haematology has set up a group to prepare an international reference method for an extended flow differential; this is intended to replace the current reference manual microscopic 2 × 200 cell count (CLSI H20-A2). Currently, there are several different protocols in use for leucocyte differential using different monoclonal antibodies and gating strategies. The aim of this study was to compare the differential results from a protocol from Singapore (SGP) with published flow cytometric protocols for the leucocyte differential from France (Faucher et al. 2007, Roussel et al. 2010) and to the automated count from the Beckman Coulter LH750 analyser and the current reference microscopic method. The French flow cytometric method uses 6 antibodies and allows detection of all white blood cells, mature neutrophils, total lymphocytes, total monocytes, eosinophils, basophils, immature granulocytes, B lymphocytes, non-cytotoxic T-lymphocytes, cytotoxic T/NK lymphocytes, CD16 positive and CD16 negative monocytes, and blasts cells with lineage orientation. The SGP method uses 8 antibodies (CD3, CD34, CD117, CD45, CD13, CD20, CD16, CD56), premixed in single tube. It detects mature neutrophils, total lymphocytes, total monocytes, eosinophils, basophils, CD16 positive and CD16 negative monocytes, T-lymphocytes, B-Lymphocytes, NK-cells, immature granulocytes and blasts. A 5-colour flow cytometer, the Beckman Coulter FC500, was used in this study. EDTA blood was analysed on 27 normal and 148 abnormal samples, either with complete blood count values outside the reference range or which demonstrated abnormal cell flags on the LH750. These samples included blast cells, immature granulocytes and abnormal lymphocytes. Results for most cell populations measured by the SGP flow differential compared well with the LH750, the manual reference method and French protocol. Comparative results using Pearson correlation are presented in Table 1. For the SGP protocol, correlation with the LH750 and with the manual differential was good for neutrophils, lymphocytes, monocytes and eosinophils. Excellent correlation was observed for all cells apart from basophils when the two flow methods were compared to each other. There was no correlation for basophils between the SGP flow method and the manual method. Similarly, there was no correlation between SGP flow method and LH750 nor between both flow methods. This is not surprising as basophils are usually present in very low numbers. Hence, without a positive marker for basophils in the flow cytometric panel correlation may depend on the type of samples used for the evaluation. Very good correlation of blast cells, r=0.99 and immature granulocytes, r=0.88 was seen between the manual and the SGP method. When comparing the flow methods to each other correlation for blast cells shows an r value of 0.96 and immature granulocytes 0.97. Our study shows that this flow cytometric method performs well with both normal and abnormal patient samples. A differential using monoclonal antibodies for immunological recognition of cells provides more information than either the manual or automated differential. In addition to the detection of the common cell populations, blast cells, immature granulocytes, subpopulations of lymphocytes and inflammatory monocytes are enumerated. Disclosures: No relevant conflicts of interest to declare.


1995 ◽  
Vol 73 (02) ◽  
pp. 291-296 ◽  
Author(s):  
Kenjiro Hamamoto ◽  
Shosaku Nomura ◽  
Masahiko Suzuki ◽  
Shigetoshi Ohga ◽  
Shirou Fukuhara

SummaryPlatelets are known to internalize monoclonal antibodies directed against the glycoprotein (GP) IIb/IIIa complex. We investigated whether an antibody directed against this complex (NNKY 2-11) was transported from the surface membrane to the intracellular pool in HEL cells. Flow cytometry showed that the percent binding of NNKY 2-11 to the surface membrane of HEL cells was decreased after incubation for 24 h compared with 1 h, while the binding of an anti-GPIb antibody (NNKY 5-5) did not change. It did not seem likely that the GP Ilb/IIIa complex antibody was shed from the surface membrane of the HEL cells during incubation, because the medium conditioned by incubation with these cells for 24 h showed almost no binding to washed platelets. In addition, immunoelectron microscopy demonstrated that GP IIb/IIIa complex antibodies were incorporated into the intracellular pool of HEL cells and were associated with alpha granules. These findings indicated that an anti-GP IIb/IIIa antibody could be internalized by megakaryocytes, as has been previously shown with platelets, suggesting that megakaryocyte GP IIb/IIIa may act as a carrier for various adhesion proteins.


1989 ◽  
Vol 93 (3) ◽  
pp. 491-500 ◽  
Author(s):  
A. Woods ◽  
T. Sherwin ◽  
R. Sasse ◽  
T.H. MacRae ◽  
A.J. Baines ◽  
...  

The detergent-insoluble T. brucei cytoskeleton consists of several morphologically distinct regions and organelles, many of which are detectable only by electron microscopy. We have produced a set of monoclonal antibodies that define each structural component of this highly ordered cytoskeleton. The monoclonal antibodies were selected by cloning of hybridomas produced from mice injected with complex mixtures of proteins of either the cytoskeleton itself or salt extracts thereof. Four antibodies define particular tubulin isotypes and locate the microtubules of the axoneme and sub-pellicular array; two antibodies recognize the flagellum attachment zone; one recognizes the paraflagellar rod and another the basal bodies. Finally, one antibody defines a detergent-insoluble component of the nucleus. The antigens detected by each monoclonal antibody have been analysed by immunofluorescence microscopy, immunogold electron microscopy and Western blotting.


Hybridoma ◽  
2010 ◽  
Vol 29 (2) ◽  
pp. 103-113 ◽  
Author(s):  
Christina Abbott ◽  
Guo Huang ◽  
Aaron R. Ellison ◽  
Ching Chen ◽  
Taruna Arora ◽  
...  

Blood ◽  
1987 ◽  
Vol 70 (4) ◽  
pp. 1063-1068
Author(s):  
JS Kristensen ◽  
J Ellegaard ◽  
P Hokland

We have developed a simple two-color immunofluorescence assay equally suited for microscopy and flow cytometry detecting hairy cells (HCs) in single cell suspensions, based on the concomitant reactivities with the B cell-specific monoclonal antibody B1 (CD20) and the monocyte/HC- associated antibody SHCL-3 (CD11c). Thus, HCs can be demonstrated in peripheral blood, bone marrow, and spleen specimens from hairy cell leukemia (HCL) patients even when they constitute less than 1% of the cell suspension. Likewise, admixture experiments with normal mononuclear cells and the MOLT-4 T-acute lymphocytic leukemia (ALL) cell line demonstrated that HCs could be detected in amounts as low as 1%. The validity of this assay has been ascertained by the lack of double marker positivity in cell suspensions from B-chronic lymphocytic leukemia (CLL) and acute myelogenous leukemia (AML) patients that only expressed B1 or SHCL-3, respectively. Furthermore, other malignant blood diseases, including malignant lymphomas, acute leukemias, and chronic leukemias disclosed no double marker positive cells. In a clinical setting, this assay was used for purifying HCs (by flow cytometry) from the peripheral blood from patients with no apparent morphological evidence of circulating HC infiltration and for monitoring the effect of interferon therapy. In conclusion, this assay should be of value for both diagnosis and monitoring patients with HCL.


1990 ◽  
Vol 116 (5) ◽  
pp. 507-512 ◽  
Author(s):  
W. Hiddemann ◽  
B. Wörmann ◽  
D. Messerer ◽  
R. Springefeld ◽  
Th. Büchner

Sign in / Sign up

Export Citation Format

Share Document